Next Article in Journal
Microbiome as a Sensitive Indicator of River Environmental Health—A Catchment-Scale Approach (Poland)
Previous Article in Journal
Thermal Conductivity and Convection Heat Transfer Coefficient of Aluminum Cellular Structures Filled with Water and Air
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Sciences
Volume 16
Issue 3
10.3390/app16031542
applsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating

by
Jung-Eun Park
1,2,
Yong-Seok Jang
1,2,
Seung-O Ko
3,4,5,* and
Min-Ho Lee
1,2,*
1
Department of Dental Biomaterials, Institute of Biodegradable Material, School of Dentistry, Jeonbuk National University, Jeonju 54896, Republic of Korea
2
Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University, Jeonju 54896, Republic of Korea
3
Department of Oral and Maxillofacial Surgery, School of Dentistry, Jeonbuk National University Dental Hospital, Jeonju 54907, Republic of Korea
4
Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju 54907, Republic of Korea
5
Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
*
Authors to whom correspondence should be addressed.
Appl. Sci. 2026, 16(3), 1542; https://doi.org/10.3390/app16031542
Submission received: 14 January 2026 / Revised: 29 January 2026 / Accepted: 31 January 2026 / Published: 3 February 2026
(This article belongs to the Topic Advances in Biomaterials—2nd Edition)
Browse Figures
Versions Notes

Abstract

Magnesium has attracted attention as an orthopedic implant material due to its excellent biocompatibility and biodegradability; however, rapid corrosion in physiological environments remains a major limitation. In this study, a polydopamine (PDA) intermediate layer and alginate/chitosan multilayer coating were formed on pure magnesium surfaces, with dexamethasone incorporation to simultaneously improve corrosion resistance and bioactivity. SEM observation revealed that uniform coating layers were formed on alginate/chitosan multilayer coated specimens, and the chemical structure of the coating layers was confirmed through FT-IR and XRD analyses. Electrochemical analysis revealed that the PDA/alginate/chitosan coating group exhibited higher corrosion potential (Ecorr: −0.7514 ± 0.022 V vs. −1.706 ± 0.001 V) and lower corrosion current density (icorr: 2.275 ± 0.15 × 10−7 A/cm2 vs. 1.528 ± 0.47 × 10−4 A/cm2) compared to pure magnesium, with the highest impedance indicating superior corrosion resistance. In tape peel testing, the polydopamine-coated group demonstrated superior adhesion compared to the non-coated group, and sustained release of dexamethasone was confirmed. MC3T3-E1 cell culture results confirmed cell proliferation in all specimens, with the PDA/alginate/chitosan group exhibiting the highest ALP activity compared to other surface-treated groups. Based on these results, the PDA/alginate/chitosan multilayer coating was confirmed to be an effective surface modification method for corrosion control and promotion of osteoblast differentiation on magnesium.

1. Introduction

Magnesium and its alloys have attracted considerable attention as next-generation biodegradable materials for orthopedic and dental implant applications due to their favorable mechanical properties similar to natural bone and complete in vivo degradation without requiring secondary surgical removal [1,2,3]. However, the excessively rapid degradation rate of magnesium in physiological environments, accompanied by hydrogen gas evolution, localized pH elevation, and premature loss of mechanical integrity, remains a critical barrier to clinical translation. Therefore, the development of surface modification techniques that can appropriately control the initial degradation rate while enhancing biological functionality is essential.
Both alloy design and surface coating technologies have been investigated to improve the corrosion resistance of magnesium and its alloys. Although the addition of alloying elements such as aluminum, zinc, and calcium demonstrates a certain degree of corrosion resistance improvement, the types of applicable elements are limited from a biocompatibility perspective, and their effects remain insufficient as fundamental solutions [4,5,6]. In contrast, surface coating techniques can effectively enhance the chemical stability of surfaces while maintaining the intrinsic mechanical properties of the substrate, offering advantages in terms of economic feasibility and practicality [7,8]. Currently utilized surface coating methods for magnesium and its alloys include dip coating [9], micro-arc oxidation [10], spin coating [11], electroless plating [12], ion implantation [13], and sol–gel [14], among others. Particularly, dip coating and spin coating are widely adopted for polymer-based coating fabrication due to their simplicity and accessibility.
Natural polymer-based coatings have been actively investigated to simultaneously achieve degradation control and enhanced cell affinity for magnesium implants [1]. Alginate (ALG), an anionic polysaccharide extracted from brown algae, possesses excellent biocompatibility and can form hydrogel structures through crosslinking with divalent cations [15,16,17,18]. Chitosan (CS), a cationic polymer obtained through deacetylation of chitin, exhibits antibacterial activity and tissue adhesive properties [19]. Layer-by-Layer (LbL) coating systems utilizing electrostatic interactions between alginate and chitosan have been proposed as promising strategies for corrosion protection of magnesium implants. However, when alginate/chitosan composite coatings are directly applied to magnesium surfaces, interfacial crack formation and insufficient adhesion strength resulting from the high chemical reactivity of magnesium limit long-term implant stability.
Polydopamine (PDA) has emerged as a promising strategy to address these interfacial adhesion challenges. PDA is a biomimetic material inspired by mussel adhesive proteins that can spontaneously form uniform nanoscale thin films on virtually any solid substrate through self-polymerization of dopamine [20,21,22,23]. PDA contains various reactive functional groups including catechol, amine, and imine moieties, enabling strong coordination and covalent bonding with metal surfaces while simultaneously promoting chemical interactions with overlying polymer layers, thus functioning as an excellent intermediate layer material. Indeed, numerous studies have reported that the introduction of PDA intermediate layers on pure magnesium surfaces significantly improves the interfacial adhesion strength and corrosion resistance of polymer coatings [24]. Therefore, in this study, a PDA intermediate layer was introduced to reinforce the interfacial adhesion between magnesium and the alginate/chitosan composite coating.
Meanwhile, the incorporation of bioactive drugs into implant surface coating systems can confer bone regeneration-promoting effects in addition to corrosion protection functionality. Dexamethasone is a synthetic glucocorticoid drug that, under appropriate concentration ranges and culture conditions, can promote osteoblast differentiation and upregulate the expression of bone formation-related genes such as alkaline phosphatase (ALP) and osteocalcin [25,26,27,28,29]. Furthermore, dexamethasone has been combined with various biomaterials including alginate, chitosan, silica, hydroxyapatite, PLGA, and collagen to fabricate hydrogels, films, nanoparticles, and microspheres for extensive applications in tissue engineering and drug delivery systems, where it has been reported to enhance cell proliferation, exhibit osteoinductive potential, and enable sustained drug release depending on the specific formulation and experimental conditions.
In this study, we aimed to develop a multifunctional surface modification strategy that addresses the key limitations of magnesium implants through an integrated approach. A PDA intermediate layer was introduced to enhance the interfacial adhesion between magnesium and polymer coatings, and an alginate/chitosan multilayer structure was applied for improved corrosion resistance along with dexamethasone loading for localized osteogenic drug delivery. This combination represents a comprehensive solution that simultaneously achieves improved adhesion, controlled degradation, and enhanced bioactivity. The surface characteristics, corrosion resistance, and cytocompatibility of the developed composite coating system were evaluated.

2. Materials and Methods

2.1. Surface Treatment of Magnesium

2.1.1. Magnesium Substrate Preparation

Pure magnesium (PM) plates (10 mm × 10 mm × 1 mm) were used as experimental substrates. For uniform polishing and removal of surface impurities, sequential grinding was performed using silicon carbide (SiC) abrasive papers in the order of #600, #800, #1000, #1500, and #2000. The polished specimens were sequentially ultrasonically cleaned with ethanol and distilled water for 10 min each, then completely dried at room temperature for subsequent experiments.

2.1.2. Polydopamine (PDA) Intermediate Layer Coating

Alkaline pretreatment was performed to enhance the adhesion of polydopamine coating on the magnesium surface. The prepared magnesium specimens were immersed in 5 M NaOH (SHOWA, Tokyo, Japan) solution and reacted at 60 °C for 12 h, then thoroughly washed with distilled water to completely remove residual alkali.
For the formation of polydopamine (PDA) intermediate layer, dopamine hydrochloride (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 50 mM Tris-HCl buffer solution (Sigma-Aldrich, St. Louis, MO, USA) to a final concentration of 10 mM, and the pH of the solution was adjusted to 8.5 using 1 M NaOH to induce self-polymerization of dopamine. The alkaline-pretreated magnesium specimens were immersed in the dopamine solution for 6 h at room temperature to perform surface coating. After coating, the specimens were thoroughly washed with distilled water and dried using nitrogen gas.

2.1.3. Alginate/Chitosan Multilayer Coating

For alginate coating, sodium alginate (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in distilled water to prepare a 1 wt% solution. Magnesium specimens (PM or PDA-coated specimens) were immersed in 1 wt% sodium alginate solution for 15 min, then washed with distilled water and dried at room temperature. The dried specimens were immersed in 0.1 M CaCl2 (SHOWA, Tokyo, Japan) solution for 5 min to induce cross-linking of alginate, then immersed in 1 wt% chitosan (Sigma-Aldrich, St. Louis, MO, USA) solution for 15 min to form a cationic polymer layer. After washing and drying, the above process was repeated 5 times to form a multilayer alginate/chitosan coating structure.

2.1.4. Dexamethasone-Loaded Alginate Coating

To provide drug delivery functionality, dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) was added to the alginate solution. Dexamethasone was dispersed in 1 wt% sodium alginate solution to a final concentration of 0.05 wt%, then uniformly mixed through ultrasonication. Subsequently, drug-loaded multilayer coating was performed by applying the same protocol as described in Section 2.1.3.

2.1.5. Specimen Classification

Each specimen prepared in this study was designated as follows:
PM: Pure Magnesium
PSC: Pure Magnesium + Sodium alginate + Chitosan
PDA: Pure Magnesium + Polydopamine
PDASC: Pure Magnesium + Polydopamine + Sodium alginate + Chitosan
PDASC-Dex: Pure Magnesium + Polydopamine + Sodium alginate + Chitosan + Dexamethasone

2.2. Surface Properties

2.2.1. Surface Analysis

The surface morphology and microstructure of the coating layers on each specimen were observed using a scanning electron microscope (SEM; SU3900, Hitachi, Tokyo, Japan). Prior to SEM observation, the specimen surfaces were sputter-coated with platinum (Pt). The elemental composition of the coating layers was analyzed using an energy dispersive X-ray spectrometer (EDS; 7274, Oxford Instruments, High Wycombe, UK).
The chemical bonding states and functional groups of the coating layers were analyzed using Fourier transform infrared spectroscopy (FT-IR, Nicolet iS50, Thermo Fisher Scientific, Waltham, MA, USA). FT-IR spectra were acquired over the wavenumber range of 4000–800 cm−1.
The crystalline phases and crystal structure of the coating layers were evaluated using an X-ray diffractometer (XRD, X’PERT-PRO Powder, PANalytical, Almelo, The Netherlands). Diffraction patterns were recorded over a 2θ range of 20–60° at a scan rate of 2°/min.
Additionally, water contact angle measurements (Phoenlx-300, SEO, Gwangju, Republic of Korea) were performed to evaluate the surface properties of the coating layers, and surface roughness was quantitatively analyzed using a surface profilometer (FTA-S4S3000, Mitutoyo, Kawasaki, Japan).

2.2.2. Corrosion Resistance Evaluation

The electrochemical corrosion behavior of the samples was evaluated by potentiodynamic polarization and electrochemical impedance spectroscopy (EIS). All electrochemical measurements were carried out using a potentiostat/galvanostat 2273 (Ametek, Berwyn, PA, USA) with Hanks’ balanced salt solution (HBSS, H2387, Sigma-Aldrich, St. Louis, MO, USA) as the electrolyte. A conventional three-electrode cell configuration was employed for all measurements. The specimen served as the working electrode, a platinum (Pt) plate as the counter electrode, and an Ag/AgCl electrode (Orion, Beverly, MA, USA) as the reference electrode. To control the exposed area, an O-ring was used to expose a precise surface area of 1 cm2 on the specimen. Potentiodynamic polarization measurements were performed by scanning the potential from −250 mV to +250 mV versus the open-circuit potential (OCP) at a scan rate of 3 mV/s. The corrosion potential (E_corr) and corrosion current density (i_corr) were determined from the obtained polarization curves using the Tafel extrapolation method. EIS measurements were performed over a frequency range of 0.1 Hz to 105 Hz.

2.2.3. Adhesion Analysis

The adhesion strength between the fabricated coatings and the PM substrate was evaluated based on digital images (EZ4E, Leica, Wetzlar, Germany) obtained after scratch testing in accordance with ASTM D3359–17 [30]. The PSC and PDASC specimens were placed on a firm base, and parallel cuts were made at 1 mm intervals. After making the required cuts, detached ribbons or flakes were removed using a soft brush, and the specimen surface was cleaned. A tape was applied to the specimen surface and then pulled off at an angle as close to 180° as possible.

2.2.4. Drug Release Test

PDASC and PDASC-Dex specimens were immersed in 1.5 mL of distilled water at 37 °C, and the immersion solution was collected at various time intervals. An equal volume of fresh distilled water was immediately replenished to the release vessel to maintain a constant total volume. The absorbance of the collected solution was measured at a wavelength of 241 nm using a UV–Vis spectrophotometer (Nano-MD, SCINCO, Seoul, Republic of Korea). The absorbance values obtained at each time point were converted to concentration using a pre-established calibration curve, and the cumulative release amount was calculated to construct a concentration–time curve.

2.3. In Vitro Test

2.3.1. Cell Culture

For the biocompatibility evaluation of each specimen, extraction media were prepared in accordance with ISO 10993.12 guidelines [31]. Magnesium specimens were immersed in cell culture medium and extracted at 37 °C in a 5% CO2 incubator for 3 days to prepare extraction media.
In this study, MC3T3-E1 murine calvarial osteoblast cells (ATCC;American Type Culture Collection, Manassas, VA, USA) were used. Cell culture medium was prepared by supplementing α-MEM (Gibco Co., Grand Island, NY, USA) with 10% fetal bovine serum (FBS; Gibco Co., Grand Island, NY, USA) and 1% penicillin-streptomycin (Gibco Co., USA). All cell cultures were maintained in an incubator (3111, Thermo Electron Corporation, Waltham, MA, USA) under conditions of 37 °C and 5% CO2.

2.3.2. Cell Viability Assessment (WST Assay)

Cell viability was evaluated using the water-soluble tetrazolium salt (WST) assay. MC3T3-E1 cells were seeded in 48-well plates at a density of 2 × 104 cells/mL, and the medium was replaced with extraction media from each specimen for culture periods of 1 and 3 days. After the culture period, the medium was removed and a solution mixture of CCK-8 reagent (Enzo Life Science Inc., Farmingdale, NY, USA) and α-MEM medium was dispensed at 400 μL per well. After incubation in a 5% CO2 incubator for 1 h, 100 μL of the reaction solution was transferred to a 96-well plate, and absorbance was measured at 450 nm using an ELISA reader (SpectraMax ABS plus, Molecular Devices, San Jose, CA, USA).

2.3.3. Cell Morphology Observation

Cells were cultured under the same conditions as the WST assay, after which the medium was removed and cells were washed twice with phosphate-buffered saline (PBS; BIOWORLD, Dublin, OH, USA). Fixative solution (3% formaldehyde + 0.2% glutaraldehyde in PBS) was added to each well and reacted for 20 min at room temperature, then washed with PBS to fix the cells. Fixed cells were stained with 0.3% crystal violet (Sigma-Aldrich, St. Louis, MO, USA) staining solution for 15 min, then washed with distilled water. Cell attachment and morphology were observed using an optical microscope (DM2500, Leica, Wetzlar, Germany).

2.3.4. Alkaline Phosphatase (ALP) Activity

Alkaline phosphatase (ALP) activity was evaluated using the TRACP & ALP assay kit (TakaRa, Kusatsu, Japan). MC3T3-E1 cells were cultured in 48-well plates at a density of 2 × 104 cells/mL for 7 and 10 days. After the culture period, the medium was removed and the plates were washed with saline. The cells were then treated with extraction solution followed by p-nitrophenyl phosphate (pNPP) solution containing ALP buffer, and incubated at 30 °C for 1 h. Subsequently, 100 μL aliquots were transferred to a 96-well plate, and absorbance was measured at 405 nm using an ELISA reader (SpectraMax ABS plus, Molecular Devices, San Jose, CA, USA).

2.4. Statistical Analysis

All experiments were performed in triplicate. Statistical analyses were conducted using one-way ANOVA. A p-value of less than 0.05 was considered to be significant (* p < 0.05).

3. Results

The surface morphology and cross-sectional structure of pure magnesium and various coated samples were observed using scanning electron microscopy (SEM), and the results are presented in Figure 1. Figure 1a shows the surface of pure magnesium (PM) before coating treatment, while Figure 1b displays the surface morphology after polydopamine (PDA) treatment alone. Distinct cracks were observed on the PDA-treated surface, exhibiting a relatively irregular surface structure (Figure 1b).
In contrast, uniform coating layers were confirmed on the surfaces of PSC, PDASC, and PDASC-Dex specimens, where alginate and chitosan were deposited using the layer-by-layer (LbL) method (Figure 1c–e). The surfaces of these specimens were uniformly covered with rounded granular structures, and the cracks observed on the PDA-only treated surface were not present. This suggests that the polyelectrolyte multilayer coating was homogeneously formed on the substrate surface.
Cross-sectional analysis of the PDASC specimen revealed that the coating layer was formed as a continuous layer with a thickness of approximately 12 μm (Figure 1f). Furthermore, energy dispersive X-ray spectroscopy (EDS) elemental mapping analysis of the PDASC cross-section (Figure 1g) showed concentrated distribution of carbon (C), oxygen (O), and calcium (Ca) elements in the coating layer region. This supports that the coating layer was formed through crosslinking between alginate and chitosan polymer chains and calcium ions.
The changes in surface roughness, wettability, chemical bonding, and crystal structure of magnesium specimens before and after coating are summarized in Figure 2.
To quantitatively evaluate changes in magnesium surface properties before and after coating, surface roughness (Ra) and contact angle were measured, and the results are shown in Figure 2a. Compared to pure magnesium (PM), specimens with PDA and alginate/chitosan coatings showed an overall increasing trend in surface roughness. Contact angle measurements revealed that PM had a contact angle of 72.68 ± 0.91°. The PDA-only treated specimen showed a sharp decrease in contact angle to 13.27 ± 0.44°, confirming significantly enhanced hydrophilicity. The PSC specimen exhibited 66.69 ± 2.70°, similar to pure magnesium, while PDASC and PDASC-Dex specimens containing PDA as a base layer showed reduced contact angles of 54.71 ± 2.43° and 56.01 ± 2.37°, respectively, compared to the PM surface. These results suggest that the high hydrophilicity of the PDA layer is partially retained even after polyelectrolyte multilayer structure formation, improving overall surface wettability.
FT-IR analysis was performed to confirm the chemical composition and functional groups of the coating layers, and the results are shown in Figure 2b. No distinct peaks were observed in untreated PM, indicating the absence of characteristic chemical functional groups on the surface. The spectrum of the PDA-coated surface showed a peak near 3691 cm−1 attributed to hydroxyl (OH) stretching vibration, and the peak observed at 1488 cm−1 was interpreted as originating from aromatic ring and N-H bending vibrations. Additionally, the peak near 1241 cm−1 corresponds to the amide III band, indicating successful polydopamine coating and imine group introduction on the surface.
The FT-IR spectra of PSC, PDASC, and PDASC-Dex specimens commonly showed a strong peak near 1390 cm−1 corresponding to symmetric stretching vibration of carboxyl groups (COO−), which is attributed to alginate chains. The peak near 1200 cm−1 can be considered as an overlap of chitosan-derived amide III band and C-O-C/C-O stretching vibrations. Notably, PDASC and PDASC-Dex specimens showed an additional amide I band near 1620 cm−1, suggesting that closer interactions including amide bonds were formed between the PDA base layer and polyelectrolyte multilayer coating.
XRD analysis was performed to confirm the crystal structure of magnesium substrates and coated specimens, and the results are shown in Figure 2c. Only characteristic peaks corresponding to magnesium (Mg) were observed in PM. In PDA and PDASC specimens that underwent NaOH pretreatment, additional peaks corresponding to magnesium hydroxide (Mg(OH)2) appeared along with Mg peaks, confirming the formation of a Mg(OH)2 conversion layer on the surface. In contrast, Mg(OH)2-related peaks were not clearly observed in PSC specimens without NaOH treatment. In PDASC-Dex specimens with dexamethasone, Mg and Mg(OH)2 peaks were observed similar to other specimens, while new diffraction peaks additionally appeared in the low-angle region. These peaks were not observed in PDASC specimens and likely correspond to partially crystalline dexamethasone (Dex) domains within the alginate-chitosan matrix, evidenced by their broad profiles indicating low crystallinity. Crystallographic indexing (hkl) was challenging due to peak overlap with Mg(OH)2 and the amorphous polymer background [32], and the absence of hydrated dexamethasone peaks suggests that dexamethasone exists predominantly in anhydrous or semi-crystalline form.
To quantitatively evaluate the corrosion inhibition effect of the coating layers, potentiodynamic polarization experiments and electrochemical impedance spectroscopy (EIS) measurements were performed in Hanks’ solution, and the results are presented in Figure 3.
Figure 3a shows the potentiodynamic polarization curves of each specimen. The corrosion potential (E_corr) was measured as −1.706 ± 0.001 V, −1.628 ± 0.068 V, −1.605 ± 0.074 V, and −0.7514 ± 0.022 V for PM, PDA, PSC, and PDASC specimens, respectively. The corrosion current density (i_corr) showed the highest value of 1.528 ± 0.47 × 10−4 A/cm2 in PM specimens, and sequentially decreased to 3.605 ± 1.61 × 10−5 A/cm2, 6.543 ± 1.10 × 10−6 A/cm2, and 2.275 ± 0.15 × 10−7 A/cm2 in PDA, PSC, and PDASC specimens, respectively. Compared to pure magnesium, all surface-treated specimens showed a positive shift in corrosion potential and a significant decrease in corrosion current density. Particularly, the PDASC group, which had polymer coating applied after PDA treatment, exhibited a substantial increase in corrosion potential and a marked decrease in corrosion current density, confirming excellent electrochemical corrosion resistance.
Figure 3b shows the Nyquist plots of electrochemical impedance spectra measured under the same conditions. The impedance response of PM specimens was fitted with an R(QR) equivalent circuit consisting of solution resistance (R_s) and a single time constant, indicating that a single charge transfer process is dominant at the electrolyte/metal interface. In contrast, PDA, PSC, and PDASC specimens were fitted with an R(Q(R(QR))) model reflecting more complex interfacial structures, indicating the existence of two different time constants at the electrolyte/coating layer interface and coating layer/substrate interface. In the Nyquist plot, the small semicircle in the high-frequency region reflects the coating resistance and capacitive behavior corresponding to the coating layer and electrolyte within its pores, while the large semicircle in the low-frequency region represents corrosion reactions related to charge transfer resistance at the magnesium substrate.
The impedance magnitude (|Z|) and semicircle diameter increased in the order of PM < PDA < PSC < PDASC, with the PDASC specimen showing the largest semicircle and highest low-frequency impedance values. This indicates that the PDA base layer and alginate/chitosan multilayer coating effectively block electrolyte penetration and significantly impede the charge transfer pathway between substrate and solution, markedly reducing the corrosion reaction rate.
The PSC specimen also showed larger semicircles and higher impedance compared to PM and PDA, supporting the protective effect of polyelectrolyte coating, and these EIS results are consistent with the decreasing trend of corrosion current density observed in potentiodynamic polarization.
Figure 4a shows the results of comparing the adhesion properties of PSC and PDASC coating layers through tape peel testing. For the PSC specimen, the surface appeared clean after tape removal, with the polymer coating entirely transferred onto the tape. In contrast, the PDASC specimen retained the polymer coating on the magnesium surface, and a considerably smaller amount of polymer was observed on the tape compared to PSC. These results confirm that the polyelectrolyte multilayer coating incorporating a PDA base layer provides superior adhesion to the substrate.
Figure 4b presents the results of evaluating the release behavior of dexamethasone over time from PDASC-Dex specimens using UV–Vis spectroscopy. The cumulative release amount calculated from absorbance of solutions collected at regular time intervals showed a gradually increasing pattern over time, suggesting that the alginate/chitosan multilayer structure achieves sustained and controlled release of dexamethasone from PDASC-Dex specimens.
Cell proliferation was evaluated by WST assay after culturing MC3T3-E1 cells in extract media obtained from each specimen for 1 and 3 days, and the results are shown in Figure 5a. On day 1, cell proliferation was at similar levels across all groups, with no statistically significant differences observed between groups (p > 0.05). On day 3, absorbance increased in all groups compared to day 1, confirming time-dependent cell proliferation. Among them, the highest cell proliferation was observed in PM, and among surface-treated specimens, the PDASC group showed a relatively higher cell proliferation trend.
Figure 5b shows the morphology of MC3T3-E1 cells stained with crystal violet after 1 and 3 days of culture under the same extract media conditions. On day 1, cells were observed to be well-attached to the surface and spread in spindle or polygonal shapes in all groups. On day 3, cell density increased overall in all groups, with cells connecting to each other and forming denser cell layers.
ALP activity was measured after culturing MC3T3-E1 cells in extract media from each specimen for 7 and 10 days, and the results are presented in Figure 5c. On day 7, relatively high absorbance (OD) values were observed in PM and PDASC groups, indicating greater induction of ALP activity in the early differentiation stage. On day 10, ALP activity showed an increasing trend compared to day 7 in all groups, with PM showing the highest OD value, and PDASC showing the highest ALP activity among surface-treated specimens. These results indicate that all specimens support MC3T3-E1 cell survival and differentiation in the magnesium extraction environment, and among them, the PDASC group showed cell proliferation and differentiation capability among the surface-treated magnesium groups.

4. Discussion

Magnesium and its alloys have been extensively studied as orthopedic implant materials due to their excellent mechanical properties and biodegradable characteristics. Magnesium has density and strength similar to natural bone, and offers the advantage of degrading in vivo, eliminating the need for secondary surgery to remove the implant [33,34]. However, the clinical application of magnesium is limited due to its rapid corrosion and the consequent rapid deterioration of mechanical properties, as well as the difficulty in controlling the timing of degradation in physiological environments [33,35]. Surface modification of magnesium to overcome these drawbacks is the most effective method for controlling corrosion and enhancing bioactivity [36,37].
In this study, polydopamine (PDA) and alginate/chitosan -based polyelectrolyte multilayer structures were utilized to simultaneously improve the corrosion resistance, cytocompatibility, and drug delivery functionality of magnesium surfaces. The PDA/SA-CS multilayer coating system proposed in this study represents an integrated surface modification strategy to overcome the excessively rapid corrosion rate of magnesium and the associated problems of alkalization and hydrogen gas evolution.
Figure 6 presents a schematic illustration of the developed coating system. Figure 6a shows the LbL fabrication process on pure magnesium, where a PDA intermediate layer was formed through self-polymerization of dopamine, followed by alginate and chitosan coating. Finally, dexamethasone was incorporated into the alginate layers during the coating process to impart drug delivery functionality. Figure 6b illustrates that the multilayer coating provides a barrier effect against electrolyte penetration in physiological environments, preventing water molecules from reaching the magnesium substrate.
SEM and EDS analysis revealed that the PDA-only coating exhibited a non-uniform cracked structure, whereas the PSC, PDASC, and PDASC-Dex specimens, prepared by layer-by-layer deposition of alginate/chitosan, displayed homogeneous coating layers with rounded granular structures continuously covering the entire substrate surface (Figure 1). The cross-sectional analysis of PDASC showed a continuous layer approximately 12 μm thick with concentrated distributions of carbon, oxygen, and calcium, suggesting the formation of a dense polyelectrolyte network through crosslinking between alginate/chitosan chains and calcium ions. FT-IR analysis confirmed the presence of both PDA-characteristic amide and aromatic peaks, as well as the carboxylate (COO−) bands of SA and amide bands derived from CS (Figure 2b), supporting the chemical immobilization of alginate/chitosan multilayers onto the Mg(OH)2/PDA underlayer. These findings are consistent with the interfacial bonding mechanisms reported in previous studies on PDA-based multilayer coatings [38].
XRD analysis revealed that only the Mg phase was observed in the pure magnesium specimen, whereas the PDA, PDASC, and PDASC-Dex specimens subjected to NaOH pretreatment exhibited additional Mg(OH)2 peaks alongside the Mg peaks, confirming the formation of a conversion layer on the surface through alkaline treatment (Figure 2c). In contrast, the PSC specimen without NaOH treatment showed no distinct Mg(OH)2-related peaks, suggesting that the formation of the conversion layer plays a critical role in the interfacial stability of the PDA underlayer and subsequent polyelectrolyte coatings [39]. The emergence of new low-angle diffraction peaks in PDASC-Dex confirms partial crystallization of Dex within the multilayer coating [40], consistent with prior reports on Dex-alginate composites where drug loading induces semi-crystalline phases [32]. The broad peak profiles reflect the low crystallinity of the alginate-chitosan matrix, which favors sustained release over burst effects (Figure 4b).
This semi-crystalline/amorphous Dex form likely enhances bioavailability by enabling controlled dissolution in physiological media, unlike fully crystalline forms that may delay initial release [41].
Electrochemical evaluation revealed that all coated specimens exhibited a positive shift in corrosion potential (E_corr) and a decrease in corrosion current density (i_corr) compared to pure magnesium, confirming that the coating layers effectively reduced the corrosion rate of magnesium (Figure 3a). Notably, the PDASC specimen showed the greatest increase in E_corr (−0.7514 ± 0.022 V) and the maximum reduction in i_corr (2.275 ± 0.15 × 10−7 A/cm2), indicating that the composite structure consisting of the Mg(OH)2 conversion layer, PDA, and alginate/chitosan multilayers functions as a protective barrier that inhibits electrolyte penetration and strongly impedes charge transfer at the substrate/solution interface. EIS analysis showed that the PM specimen was represented by a single time constant R(QR) equivalent circuit, whereas the coated specimens were best fitted with an R(Q(R(QR))) model, suggesting the presence of distinct charge transfer processes at the electrolyte/coating layer interface and the coating layer/substrate interface (Figure 3b). The progressive increase in impedance magnitude (|Z|) and semicircle diameter in the order of PM < PDA < PSC < PDASC demonstrates that the combination of alginate/chitosan multilayer coating with the PDA underlayer provides superior corrosion resistance compared to the polyelectrolyte single coating alone [39,42].
In the adhesion evaluation, the PDASC specimen exhibited less coating delamination after tape peel testing compared to PSC, which is attributed to the PDA underlayer enhancing the interfacial adhesion between the magnesium substrate and the alginate/chitosan multilayers (Figure 4a). PDA forms strong bonds with metal surfaces through its catechol and amine groups, while simultaneously forming amide bonds and hydrogen bonds with the alginate/chitosan multilayers, thereby improving the mechanical stability of the entire coating system. These results are consistent with previous reports demonstrating that the introduction of an adhesive layer in polyelectrolyte membranes enhances membrane strength and durability [43,44].
The dexamethasone release test from PDASC-Dex specimens demonstrated that cumulative release gradually increased over time, confirming successful sustained release of dexamethasone from the alginate/chitosan multilayer coating (Figure 4b). However, in this study, distilled water (pH ~ 7) was used as the release medium to evaluate fundamental drug elution kinetics from the coating matrix. This simplifies physiological conditions (e.g., lacking HBSS/α-MEM buffering salts and proteins), and the release rate may be overestimated due to the absence of ionic interactions. The sustained Dex release in distilled water (Figure 4b) confirms coating functionality; however, physiological media (e.g., HBSS) may alter release kinetics via salt/protein binding.
In cell experiments, MC3T3-E1 cells were cultured in extraction media from each specimen, and WST analysis on day 1 showed no statistically significant differences among all groups, confirming favorable initial cell viability regardless of coating status (Figure 5a). On day 3, absorbance increased in all groups, confirming time-dependent cell proliferation, with PM showing the highest values. This can be interpreted as Mg2+ released from PM under daily medium exchange conditions acting within a concentration range that promotes osteoblast proliferation and metabolic activity in the several mM range, as reported in the literature, rather than accumulating to toxic levels [45,46]. Among coated specimens, relatively higher proliferation tendency was observed in PDASC, suggesting that it provides a balanced extraction environment that supports cell proliferation while suppressing excessive corrosion.
ALP activity measurements showed an increasing trend in ALP values at both day 7 and day 10, confirming that the magnesium extraction environment generally supports MC3T3-E1 osteoblast differentiation (Figure 5c). On day 7, relatively high ALP activity was observed in PM and PDASC, and on day 10, ALP increased overall with PM showing the highest level, and PDASC showing the highest value among surface-treated specimens. This is consistent with reports that appropriate concentrations of Mg2+ can promote osteogenic differentiation by upregulating ALP and bone formation-related markers, and it is considered that PDASC coating in particular provides an ionic environment centered on Mg2+ and Ca2+ that is favorable for promoting differentiation while suppressing excessive corrosion [45,47]. Notably, PDASC-Dex did not exhibit significantly higher ALP activity compared to PDASC, despite the incorporation of dexamethasone. Literature reports effective Dex concentrations for MC3T3-E1 ALP induction range from 10 to 100 nM [25,48,49], with optimal at 50 nM [50]. Despite the sustained Dex release results (Figure 4b), the Dex concentration was likely insufficient for additional osteogenic induction due to daily medium refresh and extract dilution. Mg2+ and Ca2+ from coating primarily drove ALP upregulation [45,47]. This can be attributed to the extraction media methodology employed in this study, where the gradually released dexamethasone may not have accumulated to concentrations sufficient to elicit additional osteogenic effects beyond those provided by Mg2+ ions. Direct cell culture on specimen surfaces in future studies would better elucidate the localized drug delivery effects of the dexamethasone-loaded coating system.
While pure Mg was in this study, this PDA-mediated LbL coating strategy can also be applied to orthopedic Mg alloys with superior mechanical properties (e.g., AZ31, WE43). The universal adhesion properties of PDA and the polyelectrolyte barrier structure are expected to provide comparable levels of corrosion resistance, as demonstrated in previous studies on polymer-coated alloys.

5. Conclusions

In this study, a polydopamine (PDA) intermediate layer and alginate/chitosan multilayer coating were fabricated on pure magnesium, and dexamethasone was incorporated to simultaneously improve corrosion resistance and bioactivity. Uniform and dense multilayer coatings were formed on PSC, PDASC, and PDASC-Dex specimens, whereas PDA-only surfaces exhibited surface cracking, indicating that the alginate/chitosan multilayer effectively covered and stabilized the PDA-treated substrate.
Electrochemical analysis revealed that PDASC specimens exhibited an increased corrosion potential and a decreased corrosion current density compared to pure magnesium, demonstrating the best corrosion resistance among all groups. In addition, PDASC specimens showed superior adhesion to the magnesium substrate compared to PSC in tape adhesion testing, confirming that the PDA intermediate layer effectively enhances interfacial bonding between the metal substrate and the alginate/chitosan multilayer coating.
Dexamethasone-loaded PDASC-Dex specimens showed a gradual and sustained release profile of dexamethasone from the alginate/chitosan multilayer, verifying that the coating system can function as a localized drug delivery platform on magnesium implant surfaces. All specimens supported favorable MC3T3-E1 cell viability and osteogenic differentiation, and the PDASC group exhibited the highest ALP activity among the coated samples. Although dexamethasone is known to promote osteoblast differentiation at appropriate concentrations, the enhancement of ALP activity in the PDASC-Dex group was limited compared to PDASC alone. This is likely because the released dexamethasone did not reach sufficient concentrations under the extraction media conditions due to dilution effects and release kinetics. These results suggest that the ionic environment dominated by Mg2+ and Ca2+ released from the coated substrates played a predominant role in regulating osteogenic responses.
Taken together, these findings indicate that the PDA/alginate/chitosan multilayer coating system is an effective surface modification strategy for magnesium, achieving corrosion control, improved interfacial adhesion, sustained drug release, and promotion of osteoblast differentiation, while dexamethasone loading offers additional potential for bone regeneration support under optimized conditions.
While this study successfully demonstrated the multifunctional benefits of the PDA/alginate-chitosan-dexamethasone coating system through comprehensive in vitro characterization, several limitations should be acknowledged. The evaluation was conducted exclusively using extract media rather than direct cell culture on specimen surfaces, potentially underestimating localized drug delivery effects and cell-material interactions. Additionally, the absence of in vivo animal studies limits direct translation to physiological implant performance, and long-term mechanical integrity under simulated physiological loading was not assessed.
Future studies will address these gaps by conducting direct cell seeding experiments on coated implants to better evaluate osteoinduction and drug elution under realistic 3D culture conditions. Furthermore, comprehensive mechanical testing, including fatigue and compression under physiological loads, along with drug release kinetics in HBSS/α-MEM, will be performed to establish clinical applicability of this coating.

Author Contributions

Conceptualization, data curation, writing—original draft preparation, J.-E.P.; writing—review and editing, visualization, Y.-S.J.; supervision, S.-O.K. and M.-H.L.; project administration, M.-H.L.; funding acquisition, S.-O.K. All authors have read and agreed to the published version of the manuscript.

Funding

This paper was supported by the Fund of Biomedical Research Institute, Jeonbuk National University Hospital, and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. RS-2024-00463725).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Acknowledgments

This paper was supported by the Fund of Biomedical Research Institute, Jeonbuk National University Hospital, and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. RS-2024-00463725).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Li, L.-Y.; Cui, L.-Y.; Zeng, R.-C.; Li, S.-Q.; Chen, X.-B.; Zheng, Y.; Kannan, M.B. Advances in functionalized polymer coatings on biodegradable magnesium alloys–A review. Acta Biomater. 2018, 79, 23–36. [Google Scholar] [CrossRef]
  2. Cui, L.-Y.; Cheng, S.-C.; Liang, L.-X.; Zhang, J.-C.; Li, S.-Q.; Wang, Z.-L.; Zeng, R.-C. In vitro corrosion resistance of layer-by-layer assembled polyacrylic acid multilayers induced Ca–P coating on magnesium alloy AZ31. Bioact. Mater. 2020, 5, 153–163. [Google Scholar] [CrossRef]
  3. Shahin, M.; Munir, K.; Wen, C.; Li, Y. Magnesium matrix nanocomposites for orthopedic applications: A review from mechanical, corrosion, and biological perspectives. Acta Biomater. 2019, 96, 1–19. [Google Scholar] [CrossRef]
  4. Liu, Y.; Zheng, Y.; Chen, X.H.; Yang, J.A.; Pan, H.; Chen, D.; Wang, L.; Zhang, J.; Zhu, D.; Wu, S. Fundamental theory of biodegradable metals—Definition, criteria, and design. Adv. Funct. Mater. 2019, 29, 1805402. [Google Scholar] [CrossRef]
  5. Zhao, D.; Chen, X.; Ye, J.; Chen, T.; Dai, Y.; Liu, C.; Luo, Z.; Gao, S.; Zhang, J.; Yao, J. Simultaneously improving elastic modulus and damping capacity of extruded Mg-Gd-Y-Zn-Mn alloy via alloying with Si. J. Alloys Compd. 2019, 810, 151857. [Google Scholar] [CrossRef]
  6. Chen, L.; Sheng, Y.; Zhou, H.; Li, Z.; Wang, X.; Li, W. Influence of a MAO + PLGA coating on biocorrosion and stress corrosion cracking behavior of a magnesium alloy in a physiological environment. Corros. Sci. 2019, 148, 134–143. [Google Scholar] [CrossRef]
  7. Rakoch, A.; Monakhova, E.; Khabibullina, Z.; Serdechnova, M.; Blawert, C.; Zheludkevich, M.; Gladkova, A. Plasma electrolytic oxidation of AZ31 and AZ91 magnesium alloys: Comparison of coatings formation mechanism. J. Magnes. Alloys 2020, 8, 587–600. [Google Scholar] [CrossRef]
  8. Zou, Y.-H.; Wang, J.; Cui, L.-Y.; Zeng, R.-C.; Wang, Q.-Z.; Han, Q.-X.; Qiu, J.; Chen, X.-B.; Chen, D.-C.; Guan, S.-K. Corrosion resistance and antibacterial activity of zinc-loaded montmorillonite coatings on biodegradable magnesium alloy AZ31. Acta Biomater. 2019, 98, 196–214. [Google Scholar] [CrossRef]
  9. Fernández-Hernán, J.P.; López, A.J.; Torres, B.; Rams, J. Influence of roughness and grinding direction on the thickness and adhesion of sol-gel coatings deposited by dip-coating on AZ31 magnesium substrates. A Landau–Levich equation revision. Surf. Coat. Technol. 2021, 408, 126798. [Google Scholar] [CrossRef]
  10. Lin, Z.; Wang, T.; Yu, X.; Sun, X.; Yang, H. Functionalization treatment of micro-arc oxidation coatings on magnesium alloys: A review. J. Alloys Compd. 2021, 879, 160453. [Google Scholar] [CrossRef]
  11. Conceicao, T.F.; Scharnagl, N.; Blawert, C.; Dietzel, W.; Kainer, K. Corrosion protection of magnesium alloy AZ31 sheets by spin coating process with poly (ether imide)[PEI]. Corros. Sci. 2010, 52, 2066–2079. [Google Scholar] [CrossRef]
  12. Rajabalizadeh, Z.; Seifzadeh, D.; Habibi-Yangjeh, A.; Gundoshmian, T.M.; Nezamdoust, S. Electrochemical noise analysis to examine the corrosion behavior of Ni-P deposit on AM60B alloy plated by Zr pretreatment. Surf. Coat. Technol. 2018, 346, 29–39. [Google Scholar] [CrossRef]
  13. Jin, W.; Wu, G.; Feng, H.; Wang, W.; Zhang, X.; Chu, P.K. Improvement of corrosion resistance and biocompatibility of rare-earth WE43 magnesium alloy by neodymium self-ion implantation. Corros. Sci. 2015, 94, 142–155. [Google Scholar] [CrossRef]
  14. Samadianfard, R.; Seifzadeh, D.; Habibi-Yangjeh, A.; Jafari-Tarzanagh, Y. Oxidized fullerene/sol-gel nanocomposite for corrosion protection of AM60B magnesium alloy. Surf. Coat. Technol. 2020, 385, 125400. [Google Scholar] [CrossRef]
  15. Guo, X.; Wang, Y.; Qin, Y.; Shen, P.; Peng, Q. Structures, properties and application of alginic acid: A review. Int. J. Biol. Macromol. 2020, 162, 618–628. [Google Scholar] [CrossRef] [PubMed]
  16. Song, C.; Yang, Y.; Zhou, Y.; Wang, L.; Zhu, S.; Wang, J.; Zeng, R.; Zheng, Y.; Guan, S. Electrochemical polymerization of dopamine with/without subsequent PLLA coating on Mg-Zn-Y-Nd alloy. Mater. Lett. 2019, 252, 202–206. [Google Scholar] [CrossRef]
  17. Seki, H.; Karita, M.; Suzuki, A. The production of poly-β-hydroxybutyrate by hydrogen bacteria, Alcaligenes eutrophus H16 from alginic acid. J. Chem. Eng. Jpn. 1994, 27, 423–425. [Google Scholar] [CrossRef][Green Version]
  18. Negrini, N.C.; Bonnetier, M.; Giatsidis, G.; Orgill, D.P.; Farè, S.; Marelli, B. Tissue-mimicking gelatin scaffolds by alginate sacrificial templates for adipose tissue engineering. Acta Biomater. 2019, 87, 61–75. [Google Scholar] [CrossRef] [PubMed]
  19. Kozina, I.; Krawiec, H.; Starowicz, M.; Kawalec, M. Corrosion resistance of MgZn alloy covered by chitosan-based coatings. Int. J. Mol. Sci. 2021, 22, 8301. [Google Scholar] [CrossRef]
  20. Lee, H.; Lee, B.P.; Messersmith, P.B. A reversible wet/dry adhesive inspired by mussels and geckos. Nature 2007, 448, 338–341. [Google Scholar] [CrossRef]
  21. Liang, L.; Guo, X.; Liao, X.; Chang, Z. Improve the interfacial adhesion, corrosion resistance and combustion properties of aluminum powder by modification of nickel and dopamine. Appl. Surf. Sci. 2020, 508, 144790. [Google Scholar] [CrossRef]
  22. Mu, Y.; Mu, P.; Wu, X.; Wan, X. The two facets of the synergic effect of amine cation and catechol on the adhesion of catechol in underwater conditions. Appl. Surf. Sci. 2020, 530, 146973. [Google Scholar] [CrossRef]
  23. Baby, M.; Periya, V.K.; Sankaranarayanan, S.K.; Maniyeri, S.C. Bioinspired surface activators for wet/dry environments through greener epoxy-catechol amine chemistry. Appl. Surf. Sci. 2020, 505, 144414. [Google Scholar] [CrossRef]
  24. Wang, C.; Shen, J.; Xie, F.; Duan, B.; Xie, X. A versatile dopamine-induced intermediate layer for polyether imides (PEI) deposition on magnesium to render robust and high inhibition performance. Corros. Sci. 2017, 122, 32–40. [Google Scholar] [CrossRef]
  25. Costa, P.F.; Puga, A.M.; Díaz-Gomez, L.; Concheiro, A.; Busch, D.H.; Alvarez-Lorenzo, C. Additive manufacturing of scaffolds with dexamethasone controlled release for enhanced bone regeneration. Int. J. Pharm. 2015, 496, 541–550. [Google Scholar] [CrossRef]
  26. Chen, Y.; Kawazoe, N.; Chen, G. Preparation of dexamethasone-loaded biphasic calcium phosphate nanoparticles/collagen porous composite scaffolds for bone tissue engineering. Acta Biomater. 2018, 67, 341–353. [Google Scholar] [CrossRef]
  27. He, J.; Zhang, Y.; Liu, X.; Li, H.; Xiong, C.; Zhang, L. Load-bearing PTMC-beta tri-calcium phosphate and dexamethasone biphasic composite microsphere scaffolds for bone tissue engineering. Mater. Lett. 2020, 260, 126939. [Google Scholar] [CrossRef]
  28. Zhou, X.; Liu, P.; Nie, W.; Peng, C.; Li, T.; Qiang, L.; He, C.; Wang, J. Incorporation of dexamethasone-loaded mesoporous silica nanoparticles into mineralized porous biocomposite scaffolds for improving osteogenic activity. Int. J. Biol. Macromol. 2020, 149, 116–126. [Google Scholar] [CrossRef]
  29. Tavakoli-darestani, R.; Manafi-rasi, A.; Kamrani-rad, A. Dexamethasone-loaded hydroxyapatite enhances bone regeneration in rat calvarial defects. Mol. Biol. Rep. 2014, 41, 423–428. [Google Scholar] [CrossRef]
  30. ASTM D3359-17; Standard Test Methods for Rating Adhesion by Tape Test. American Society of Testing Materials: West Conshohocken, PA, USA, 2017.
  31. Wallin, R.F. A Practical Guide to ISO 10993-12: Sample Preparation and Reference Materials; MDDI: Los Angeles, CA, USA, 1998. [Google Scholar]
  32. Rahvar, M.; Ahmadi Lakalayeh, G.; Nazeri, N.; Marouf, B.T.; Shirzad, M.; Najafi, T.; Shabankareh, A.; Ghanbari, H. Assessment of structural, biological and drug release properties of electro-sprayed poly lactic acid-dexamethasone coating for biomedical applications. Biomed. Eng. Lett. 2021, 11, 393–406. [Google Scholar] [CrossRef] [PubMed]
  33. Lu, Y.; Deshmukh, S.; Jones, I.; Chiu, Y.-L. Biodegradable magnesium alloys for orthopaedic applications. Biomater. Transl. 2021, 2, 214. [Google Scholar] [PubMed]
  34. Wang, Z.; Liu, B.; Yin, B.; Zheng, Y.; Tian, Y.; Wen, P. Comprehensive review of additively manufactured biodegradable magnesium implants for repairing bone defects from biomechanical and biodegradable perspectives. Front. Chem. 2022, 10, 1066103. [Google Scholar] [CrossRef] [PubMed]
  35. Pogorielov, M.; Husak, E.; Solodivnik, A.; Zhdanov, S. Magnesium-based biodegradable alloys: Degradation, application, and alloying elements. Interv. Med. Appl. Sci. 2017, 9, 27–38. [Google Scholar] [CrossRef]
  36. Zhang, T.; Wang, W.; Liu, J.; Wang, L.; Tang, Y.; Wang, K. A review on magnesium alloys for biomedical applications. Front. Bioeng. Biotechnol. 2022, 10, 953344. [Google Scholar] [CrossRef] [PubMed]
  37. Tian, P.; Liu, X. Surface modification of biodegradable magnesium and its alloys for biomedical applications. Regen. Biomater. 2015, 2, 135–151. [Google Scholar] [CrossRef]
  38. Lawrie, G.; Keen, I.; Drew, B.; Chandler-Temple, A.; Rintoul, L.; Fredericks, P.; Grøndahl, L. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules 2007, 8, 2533–2541. [Google Scholar] [CrossRef]
  39. Jia, R.; He, Y.; Liang, J.; Duan, L.; Ma, C.; Lu, T.; Liu, W.; Li, S.; Wu, H.; Cao, H. Preparation of biocompatibility coating on magnesium alloy surface by sodium alginate and carboxymethyl chitosan hydrogel. Iscience 2024, 27, 109197. [Google Scholar] [CrossRef]
  40. Zhang, R.; Lei, L.; Song, Q.; Li, X. Calcium ion cross-linking alginate/dexamethasone sodium phosphate hybrid hydrogel for extended drug release. Colloids Surf. B Biointerfaces 2019, 175, 569–575. [Google Scholar] [CrossRef]
  41. Miles, C.E.; Bernstein, A.D.; Osborn Popp, T.M.; Murthy, N.S.; Nieuwkoop, A.J.; Gormley, A.J. Control of drug release from microparticles by tuning their crystalline textures: A structure–activity study. ACS Appl. Polym. Mater. 2021, 3, 6548–6561. [Google Scholar] [CrossRef]
  42. Carangelo, A.; Acquesta, A.; Monetta, T. In-vitro corrosion of AZ31 magnesium alloys by using a polydopamine coating. Bioact. Mater. 2019, 4, 71–78. [Google Scholar] [CrossRef]
  43. Singer, F.; Schlesak, M.; Mebert, C.; Höhn, S.; Virtanen, S. Corrosion properties of polydopamine coatings formed in one-step immersion process on magnesium. ACS Appl. Mater. Interfaces 2015, 7, 26758–26766. [Google Scholar] [CrossRef] [PubMed]
  44. Dong, J.; Zhong, J.; Hou, R.; Hu, X.; Chen, Y.; Weng, H.; Zhang, Z.; Liu, B.; Yang, S.; Peng, Z. Polymer bilayer-Micro arc oxidation surface coating on pure magnesium for bone implantation. J. Orthop. Transl. 2023, 40, 27–36. [Google Scholar] [CrossRef]
  45. He, L.; Zhang, X.; Liu, B.; Tian, Y.; Ma, W. Effect of magnesium ion on human osteoblast activity. Braz. J. Med. Biol. Res. 2016, 49, e5257. [Google Scholar] [CrossRef] [PubMed]
  46. Nie, X.; Sun, X.; Wang, C.; Yang, J. Effect of magnesium ions/Type I collagen promote the biological behavior of osteoblasts and its mechanism. Regen. Biomater. 2020, 7, 53–61. [Google Scholar] [CrossRef] [PubMed]
  47. Miyake, R.; Shimabukuro, M.; Terauchi, M.; Marukawa, E.; Kawashita, M. Osteogenic Effects of Ion Released from Biodegradable Metallic Magnesium and Calcium Coating. Adv. Biol. 2025, 9, e00401. [Google Scholar] [CrossRef]
  48. Park, J.B. Effects of the combination of dexamethasone and fibroblast growth factor-2 on differentiation of osteoprecursor cells. Mol. Med. Rep. 2014, 9, 659–662. [Google Scholar] [CrossRef][Green Version]
  49. Ghali, O.; Broux, O.; Falgayrac, G.; Haren, N.; Van Leeuwen, J.P.; Penel, G.; Hardouin, P.; Chauveau, C. Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation. BMC Cell Biol. 2015, 16, 9. [Google Scholar] [CrossRef]
  50. Miyahara, T.; Nemoto, M.; Tukamoto, S.; Yamada, H.; Kozuka, H.; Kuze, S.; Sudo, H.; Yamamoto, S. Induction of metallothionein and stimulation of calcification by dexamethasone in cultured clonal osteogenic cells, MC3T3-E1. Toxicol. Lett. 1991, 57, 257–267. [Google Scholar] [CrossRef]
Applsci 16 01542 g001
Figure 1. SEM images showing surface morphology and cross-sectional structure of pure magnesium and coated samples: (a) PM, (b) PDA, (c) PSC, (d) PDASC, (e) PDASC-Dex and (f) cross-sectional image of PDASC specimen. (g) EDS elemental mapping of PDASC cross-section.
Figure 1. SEM images showing surface morphology and cross-sectional structure of pure magnesium and coated samples: (a) PM, (b) PDA, (c) PSC, (d) PDASC, (e) PDASC-Dex and (f) cross-sectional image of PDASC specimen. (g) EDS elemental mapping of PDASC cross-section.
Applsci 16 01542 g001
Applsci 16 01542 g002
Figure 2. Surface characterization of pure magnesium and coated samples: (a) surface roughness and water contact angle (b) FT−IR spectra and (c) XRD patterns.
Figure 2. Surface characterization of pure magnesium and coated samples: (a) surface roughness and water contact angle (b) FT−IR spectra and (c) XRD patterns.
Applsci 16 01542 g002
Applsci 16 01542 g003
Figure 3. Electrochemical corrosion resistance of pure magnesium and coated samples in Hanks’ solution: (a) potentiodynamic polarization curves and corresponding electrochemical parameters, and (b) Nyquist plots from EIS measurements fitted with equivalent circuits R(QR) for PM and R(Q(R(QR))) for PDA, PSC, and PDASC samples.
Figure 3. Electrochemical corrosion resistance of pure magnesium and coated samples in Hanks’ solution: (a) potentiodynamic polarization curves and corresponding electrochemical parameters, and (b) Nyquist plots from EIS measurements fitted with equivalent circuits R(QR) for PM and R(Q(R(QR))) for PDA, PSC, and PDASC samples.
Applsci 16 01542 g003
Applsci 16 01542 g004
Figure 4. Adhesion strength and UV–Vis drug release profiles of coated samples: (a) tape adhesion test for PSC and PDASC coatings and (b) cumulative dexamethasone release from PDASC-Dex measured by UV–Vis spectroscopy.
Figure 4. Adhesion strength and UV–Vis drug release profiles of coated samples: (a) tape adhesion test for PSC and PDASC coatings and (b) cumulative dexamethasone release from PDASC-Dex measured by UV–Vis spectroscopy.
Applsci 16 01542 g004
Applsci 16 01542 g005
Figure 5. Cell responses of MC3T3-E1 cultured in extract media from pure magnesium and coated samples: (a) WST assay (1 and 3 days), (b) cell morphology after crystal violet staining (1 and 3 days), and (c) ALP activity (7 and 10 days) (one-way ANOVA with Tukey’s test; ns p > 0.05).
Figure 5. Cell responses of MC3T3-E1 cultured in extract media from pure magnesium and coated samples: (a) WST assay (1 and 3 days), (b) cell morphology after crystal violet staining (1 and 3 days), and (c) ALP activity (7 and 10 days) (one-way ANOVA with Tukey’s test; ns p > 0.05).
Applsci 16 01542 g005
Applsci 16 01542 g006
Figure 6. Schematic illustration of (a) the layer-by-layer fabrication process of PDA/alginate-chitosan multilayer coating with dexamethasone loading on pure magnesium, and (b) the corrosion protection mechanism showing barrier effect against electrolyte penetration.
Figure 6. Schematic illustration of (a) the layer-by-layer fabrication process of PDA/alginate-chitosan multilayer coating with dexamethasone loading on pure magnesium, and (b) the corrosion protection mechanism showing barrier effect against electrolyte penetration.
Applsci 16 01542 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Park, J.-E.; Jang, Y.-S.; Ko, S.-O.; Lee, M.-H. Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating. Appl. Sci. 2026, 16, 1542. https://doi.org/10.3390/app16031542

AMA Style

Park J-E, Jang Y-S, Ko S-O, Lee M-H. Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating. Applied Sciences. 2026; 16(3):1542. https://doi.org/10.3390/app16031542

Chicago/Turabian Style

Park, Jung-Eun, Yong-Seok Jang, Seung-O Ko, and Min-Ho Lee. 2026. "Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating" Applied Sciences 16, no. 3: 1542. https://doi.org/10.3390/app16031542

APA Style

Park, J.-E., Jang, Y.-S., Ko, S.-O., & Lee, M.-H. (2026). Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating. Applied Sciences, 16(3), 1542. https://doi.org/10.3390/app16031542

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop